Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Chubb
Healthtrust
Federal Trade Commission
US Department of Justice
Queensland Health
Citi
UBS
Accenture
Chinese Patent Office

Generated: January 22, 2018

DrugPatentWatch Database Preview

ILOSONE Drug Profile

« Back to Dashboard

When do Ilosone patents expire, and when can generic versions of Ilosone launch?

Ilosone is a drug marketed by Lilly and Dista and is included in seven NDAs.

The generic ingredient in ILOSONE is erythromycin estolate; sulfisoxazole acetyl. There are one hundred and one drug master file entries for this compound. Additional details are available on the erythromycin estolate; sulfisoxazole acetyl profile page.

US Patents and Regulatory Information for ILOSONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly ILOSONE erythromycin estolate CAPSULE;ORAL 061897-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly ILOSONE erythromycin estolate SUSPENSION;ORAL 061894-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly ILOSONE erythromycin estolate SUSPENSION/DROPS;ORAL 061894-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly ILOSONE SULFA erythromycin estolate; sulfisoxazole acetyl SUSPENSION;ORAL 050599-001 Sep 29, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly ILOSONE erythromycin estolate SUSPENSION;ORAL 050010-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly ILOSONE erythromycin estolate CAPSULE;ORAL 061897-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dista ILOSONE erythromycin estolate FOR SUSPENSION;ORAL 061893-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly ILOSONE erythromycin estolate SUSPENSION;ORAL 050010-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly ILOSONE erythromycin estolate SUSPENSION;ORAL 061894-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dista ILOSONE erythromycin estolate TABLET, CHEWABLE;ORAL 061895-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Queensland Health
Argus Health
QuintilesIMS
Harvard Business School
Cerilliant
Express Scripts
Novartis
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot